| Trial ID: | L5843 |
| Source ID: | NCT00131287
|
| Associated Drug: |
Extract Of Agaricus Blazei Murill
|
| Title: |
The Supplementary Effects of the Extract of Agaricus Blazei Murril on Type II Diabetes Mellitus (DM)
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type II
|
| Interventions: |
DRUG: Extract of Agaricus blazei Murill
|
| Outcome Measures: |
Primary: Percent reduction of glycated hemoglobin (HAb1C) and insulin resistance(HOMA-IR) | Secondary: Glucose, cholesterol, triglyceride, leptin, adiponectin comparisons
|
| Sponsor/Collaborators: |
Sponsor: ECbiotech Taiwan
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
108
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2005-07
|
| Completion Date: |
2006-12
|
| Results First Posted: |
|
| Last Update Posted: |
2010-01-05
|
| Locations: |
Chung-Hua Hsu, Taipei, 886, Taiwan
|
| URL: |
https://clinicaltrials.gov/show/NCT00131287
|
